Bioengineered Organ Implant Developer Biostage Webcasts LD Micro Conference Presentation Tuesday, June 7 at 1:00 pm PT

June 3, 2016 10:31 AM

LOS ANGELES, CA / ACCESSWIRE / June 3, 2016 / Biostage, Inc. (NASDAQ: BSTG), a biotechnology company developing bioengineered organ implants to treat cancer and other life-threatening conditions of the esophagus, bronchus and trachea, today announced that CFO Tom McNaughton will present at the LD Micro Investor Conference on Tuesday, June 7th at 1:00 pm PT (4:00 pm ET) in Los Angeles. LD Micro Invitational Conference: Date: Tuesday, June 7th,...

Read more

Cellectar Biosciences to Present at the LD Micro Invitational

June 2, 2016 8:30 AM

MADISON, WI and LOS ANGELES, CA / ACCESSWIRE / June 2, 2016 / Cellectar Biosciences (Nasdaq: CLRB), an oncology-focused biotechnology company, today announced that it will be presenting at the 6th annual LD Micro Invitational on Thursday, June 9 at 9:30 AM PST/12:30 PM EST. Jim Caruso, president and CEO of Cellectar, will present the company and meet with investors. "As we continue to successfully advance our operating plan and clinical...

Read more

RBCC: Customized Pills Show the Power and Potential of Personalized Medicine

June 2, 2016 8:27 AM

HENDERSON, NV / ACCESSWIRE / June 2, 2016 / Rainbow Coral Corp. (OTCQB: RBCC) continues to seek new opportunities and breakthroughs in personalized medicine and recent news from Singapore could offer the company the ground floor chance it has been looking for to become a leader in this rapidly growing field. Scientists in the southeast Asian nation have announced they have invented a means to 3D print medications customized to suit...

Read more

BioNovelus Executives to Tour Costa Rica

May 23, 2016 5:00 AM

SCOTTSDALE, AZ / ACCESSWIRE / May 23, 2016 / BioNovelus, Inc. (PINKSHEETS: ONOV) BioNovelus executives President and CEO Jean Ekobo, and CFO, Mark Johnson, will be in Costa Rica the week of May 23, 2016 touring and evaluating five coffee farms participating in a Pilot Test that has revealed CR-10 to be an effective coffee leaf rust killer. Additionally, BioNovelus has signed a Letter of Intent with a prominent Costa Rican distribution company...

Read more

Upcoming Opioid Addiction Action in Congress Could Mean Opportunities for RBCC

May 23, 2016 5:00 AM

HENDERSON, NV / ACCESSWIRE / May 23, 2016 / Spurred by the ever-growing opioid addiction crisis, the U.S. Congress is now busy refining bipartisan legislation aimed at providing help and relief for those hooked on prescription drugs. This prospect could bode well for Rainbow Coral Corp. (OTCQB: RBCC) as it develops a new addiction treatment program utilizing Naltrexone, an anti-addiction medication. The U.S. House of Representatives has passed...

Read more

Lotus Bio-Technology Development, Corp. Establishes New Corporate Office and Appoints Successful Veteran Entrepreneur as President and Chief Executive Officer

May 18, 2016 9:12 AM

PHOENIX, AZ / ACCESSWIRE / May 18, 2016 / Lotus Bio-Technology Development, Corp. (OTC: LBTD) a Bio-naturals company specializing in exploring for opportunities in the refining of organic materials for the production of consumer related products, announces today the Grand Opening of the Company's new corporate office in China, and the appointment of Michael Palethorpe as the Company's new Chief Executive Officer and President. Having...

Read more

BioNovelus Announces the New Board of Directors

May 11, 2016 11:20 AM

SCOTTSDALE, AZ / ACCESSWIRE / May 11, 2016 / BioNovelus, Inc. (PINKSHEETS: ONOV) is pleased to announce its new Board of Directors. On May 3, 2016, the company held its quarterly Board of Directors meeting with the majority of shareholders present. "All four of our newest Board members embody the spirit of sustainability: People, Planet, and Profit, and bring talent, expertise, energy and passion to the table," says Jean Ekobo, President/CEO of...

Read more

BioNovelus Announces the New Board of Directors

May 11, 2016 9:36 AM

SCOTTSDALE, AZ / ACCESSWIRE / May 11, 2016 / BioNovelus, Inc. (PINKSHEETS: ONOV) is pleased to announce its new Board of Directors. On May 3, 2016, the company held its quarterly Board of Directors meeting with the majority of shareholders present. "All four of our newest Board members embody the spirit of sustainability: People, Planet, and Profit, and bring talent, expertise, energy and passion to the table," says Jean Ekobo, President/CEO of...

Read more

Independent Forecast Justifies RBCC's Focus on Booming Personalized Medicine Market

May 9, 2016 10:04 AM

HENDERSON, NV / ACCESSWIRE / May 9, 2016 / Personalized (or precision) medicine continues a surge that shows no signs of stopping, and according to an independent research report the total market could top $88 billion within six years. The glowing report comes as welcome news for Rainbow Coral Corp. (OTCQB: RBCC), which has been active on several personalized medicine fronts recently, and bolsters the company's ambitions to someday be a leader...

Read more

BioNovelus Product CR-10 Set to Save Coffee Industry!

May 5, 2016 7:00 AM

SCOTTSDALE, AZ / ACCESSWIRE / May 5, 2016 / BioNovelus, Inc. (PINKSHEETS: ONOV) is pleased to announce the triumph of CR-10, their environmentally friendly fungicide product. Test results in five coffee plantations have proven that biodegradable CR-10 is a coffee rust killer! Coffee rust or "roya" (Hemileia vastatrix) is a devastating fungus that has already cost $2.5B to the coffee industry and 500,000 jobs in Central America since 2012....

Read more

Vitro Biopharma Launches New Products to Advance Breast Cancer Treatment

May 3, 2016 9:30 AM

GOLDEN, CO / ACCESSWIRE / May 3, 2016 / Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the launch of breast cancer CAFs (cancer-associated fibroblasts) that provide additional tools for drug discovery in the quest to eradicate cancer. CAFs reside within tumor tissue and serve various functions including suppression of immune responses to cancerous cells, support of tumor cell growth and enhancement of metastasis. Modern...

Read more

U.S. Drug Overdose Deaths Hit Record High, Opening Door for RBCC to Offer Solutions

April 27, 2016 5:00 AM

HENDERSON, NV / ACCESSWIRE / April 27, 2016 / Recently released overdose mortality statistics paint a grim picture of America's battle against prescription drug addiction, and while the portrait isn't pretty, Rainbow Coral Corp. (OTCQB: RBCC) believes the dire numbers may have at last spurred industry and government to find a workable answer. According to numbers issued by the Centers for Disease Control (CDC), more than 47,000 people died...

Read more

RBCC: Sobering Stats Show Growing Need for Affordable Alcoholism Treatment

April 4, 2016 5:00 AM

HENDERSON, NV / ACCESSWIRE / April 4, 2016 / Recent scientific research has shown that alcohol is among the 10 most addictive drugs in existence, and trails only tobacco among legally obtainable substances and ranks nearly as potent as barbiturates when illegal ones are included. Rainbow Coral Corp. (OTCQB: RBCC) takes these findings as a serious sign that more research and treatment options are needed in order to successfully combat alcohol's...

Read more

UCSF and Accurexa Receive Response From FDA to Pre-IND Meeting Request

March 24, 2016 8:00 AM

NEWARK, DE / ACCESSWIRE / March 24, 2016 / the "Company" or "Accurexa") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that the University of California, San Francisco ("UCSF") received a written response from the FDA (U.S. Food and Drug Administration) regarding a pre-IND meeting request to discuss a collaborative program between UCSF and...

Read more

Hydromer Inc Announces the Release of a New Abrasion Resistant Anti-Fog Coating

March 21, 2016 11:39 AM

The New ABRATE-X518TM Coating Brings Innovative Technology to the Growing Consumer and Industrial MarketBRANCHBURG, NJ / ACCESSWIRE / March 21, 2016 / Hydromer, Inc. (OTCPINK: HYDI) announces the release of a substantial technological advancement in abrasion resistant anti-fog coatings. This specialty coating will be marketed under the "ABRATE-X518(TM)" brand.Hydromer invested over 5 years of research and development in the scientific...

Read more

Accurexa Initiates Preparation of Pre-IND Meeting for its ACX-31 Program

March 17, 2016 8:00 AM

NEWARK, DE / ACCESSWIRE / March 17, 2016 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that it has initiated the preparation of a pre-IND meeting for its ACX-31 program for the local delivery of temozolomide in combination with BCNU, both chemotherapeutics, in the treatment of brain tumors. "We are excited...

Read more

Algae Dynamics Corp Announces Effectiveness of S-1 Registration Statement

March 4, 2016 8:35 AM

TORONTO, ON / ACCESSWIRE / March 4, 2016 / ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation system for the growth of algae strains for use in the food and health supplement industry, announced today that its S-1 Registration Statement filing has been declared effective by the Securities & Exchange Commission as of March 3, 2016. The...

Read more

mPhase to Pursue Smart Drug Delivery Systems

February 29, 2016 9:20 AM

CLIFTON, NJ / ACCESSWIRE / February 29, 2016 / mPhase Technologies, Inc. (OTC: XDSL), announced today that the recent Notice of Allowance for a patent covering a Smart Drug Delivery System generated interest at The National Investment Banking Association (NIBA) conference in Hollywood, FL. The inquiries from the presentation titled "A Challenging Journey from Smart Batteries to Smart Drug Delivery Systems" along with the Notice of Allowance for...

Read more

Nutra Pharma To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

February 18, 2016 9:00 AM

CORAL SPRINGS, FL / ACCESSWIRE / February 18, 2016 / Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, today announced that the company will present at the SeeThruEquity & The Brewer Group 2nd...

Read more

Accurexa Engages PharmaLex to Advance its ACX-31 Program towards a Regulatory Path

February 10, 2016 8:00 AM

NEWARK, DE / ACCESSWIRE / February 10, 2016 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that it has engaged PharmaLex Development Services, LLC ("PharmaLex") to advise the Company in the development of its ACX-31 program for the local delivery of temozolomide in combination with BCNU, both...

Read more